Maitray A. Patel

774 total citations
20 papers, 379 citations indexed

About

Maitray A. Patel is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Maitray A. Patel has authored 20 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Neurology and 6 papers in Epidemiology. Recurrent topics in Maitray A. Patel's work include COVID-19 Clinical Research Studies (10 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Long-Term Effects of COVID-19 (5 papers). Maitray A. Patel is often cited by papers focused on COVID-19 Clinical Research Studies (10 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Long-Term Effects of COVID-19 (5 papers). Maitray A. Patel collaborates with scholars based in Canada, United States and Italy. Maitray A. Patel's co-authors include Douglas D. Fraser, Mark Daley, Gediminas Cepinskas, Eric K. Patterson, Claudio M. Martin, Michael R. Miller, Marat Slessarev, David B. O’Gorman, Sean E. Gill and Logan R. Van Nynatten and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Injury.

In The Last Decade

Maitray A. Patel

18 papers receiving 374 citations

Peers

Maitray A. Patel

NEURO

EPIDE

PRM

Petrus Johannes Lourens United Kingdom

Huiguo Liu China

William Ottestad Norway

Sergiy G. Gychka Ukraine

Marina Rieder Germany

Zachary Manickas-Hill United States

Simone Turner Denmark

Elizabeth Zapata Colombia

Sant Ram India

Petrus Johannes Lourens United Kingdom

Maitray A. Patel

226 ×1.2

177 ×1.1

NEURO

53 ×0.7

47 ×0.6

EPIDE

73 ×1.5

PRM

Citations per year, relative to Maitray A. Patel Maitray A. Patel (= 1×) peers Petrus Johannes Lourens

Countries citing papers authored by Maitray A. Patel

Since Specialization

Citations

This map shows the geographic impact of Maitray A. Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maitray A. Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maitray A. Patel more than expected).

Fields of papers citing papers by Maitray A. Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maitray A. Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maitray A. Patel. The network helps show where Maitray A. Patel may publish in the future.

Co-authorship network of co-authors of Maitray A. Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Maitray A. Patel. A scholar is included among the top collaborators of Maitray A. Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maitray A. Patel. Maitray A. Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spagnolo, P., Enis Cela, Maitray A. Patel, et al.. (2025). Differential expression of plasma proteins and pathway enrichments in pediatric diabetic ketoacidosis. Molecular Medicine. 31(1). 4–4. 2 indexed citations

Fraser, Douglas D., Devika Singh, Enis Cela, et al.. (2025). Neutralizing antibodies to SARS-CoV-2 variants of concern: a pediatric surveillance study. Scientific Reports. 15(1). 11588–11588.

Nynatten, Logan R. Van, Maitray A. Patel, Michael R. Miller, et al.. (2025). Putative biomarkers of hepatic dysfunction in critically ill sepsis patients. Clinical and Experimental Medicine. 25(1). 28–28. 3 indexed citations

Leonard, Sean, Michael R. Miller, Maitray A. Patel, et al.. (2024). Pediatric sepsis inflammatory blood biomarkers that correlate with clinical variables and severity of illness scores. Journal of Inflammation. 21(1). 3 indexed citations

Patel, Maitray A., et al.. (2024). The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis. Molecular Medicine. 30(1). 3 indexed citations

Patel, Maitray A., et al.. (2024). A reduced proteomic signature in critically ill Covid-19 patients determined with plasma antibody micro-array and machine learning. Clinical Proteomics. 21(1). 33–33. 2 indexed citations

Patel, Maitray A., Michael J. Knauer, Mark Daley, et al.. (2023). Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning. Molecular Medicine. 29(1). 26–26. 25 indexed citations

Nynatten, Logan R. Van, Michael R. Miller, Maitray A. Patel, et al.. (2023). A novel multiplex biomarker panel for profiling human acute and chronic kidney disease. Scientific Reports. 13(1). 21210–21210. 9 indexed citations

Fraser, Douglas D., Maitray A. Patel, Logan R. Van Nynatten, et al.. (2022). Cross-immunity against SARS-COV-2 variants of concern in naturally infected critically ill COVID-19 patients. Heliyon. 9(1). e12704–e12704. 4 indexed citations

10.

Miller, Michael R., Alicia DiBattista, Maitray A. Patel, et al.. (2022). A Distinct Metabolite Signature in Military Personnel Exposed to Repetitive Low-Level Blasts. Frontiers in Neurology. 13. 831792–831792. 5 indexed citations

11.

Nynatten, Logan R. Van, Marat Slessarev, Claudio M. Martin, et al.. (2022). Novel plasma protein biomarkers from critically ill sepsis patients. Clinical Proteomics. 19(1). 50–50. 13 indexed citations

12.

Daley, Mark, Saoirse Cameron, Saptharishi Lalgudi Ganesan, et al.. (2022). Pediatric severe traumatic brain injury mortality prediction determined with machine learning-based modeling. Injury. 53(3). 992–998. 16 indexed citations

13.

Patel, Maitray A., Michael J. Knauer, Mark Daley, et al.. (2022). Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism. Molecular Medicine. 28(1). 67 indexed citations

14.

Gerotziafas, Grigoris, Patrick Van Dreden, Douglas D. Fraser, et al.. (2022). The COMPASS-COVID-19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19. SHILAP Revista de lepidopterología. 3(1). 204–218.

15.

Miller, Michael R., Michael Robinson, Lisa Fischer, et al.. (2021). Putative Concussion Biomarkers Identified in Adolescent Male Athletes Using Targeted Plasma Proteomics. Frontiers in Neurology. 12. 787480–787480. 8 indexed citations

16.

Fraser, Douglas D., Gediminas Cepinskas, Marat Slessarev, et al.. (2021). Detection and Profiling of Human Coronavirus Immunoglobulins in Critically Ill Coronavirus Disease 2019 Patients. Critical Care Explorations. 3(3). e0369–e0369. 7 indexed citations

17.

Fraser, Douglas D., Gediminas Cepinskas, Marat Slessarev, et al.. (2021). Critically Ill COVID-19 Patients Exhibit Anti-SARS-CoV-2 Serological Responses. Pathophysiology. 28(2). 212–223. 6 indexed citations

18.

Fraser, Douglas D., Eric K. Patterson, Marat Slessarev, et al.. (2020). Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation. Critical Care Explorations. 2(9). e0194–e0194. 83 indexed citations

19.

Fraser, Douglas D., Gediminas Cepinskas, Eric K. Patterson, et al.. (2020). Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients. Critical Care Explorations. 2(9). e0189–e0189. 42 indexed citations

20.

Fraser, Douglas D., Marat Slessarev, Claudio M. Martin, et al.. (2020). Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers. Critical Care Explorations. 2(10). e0272–e0272. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact